Other therapies Ch 11
Page 1 / 16

Many other therapies are used to treat cancer. Their utility is of great importance, in particular in offering patient comfort (see also chapter on palliative care). They are curiously grouped together in this chapter although their action mechanisms and their modalities are very different. In the near future, some of these therapies will benefit from an individual chapter (for instance: targeted treatments).

Main therapies studied in this chapter

Diphosphonates are used for treating bone metastases

Classical immunotherapy

Passive non specific immunotherapy

Interferon

Interleukin

Non specific active immunotherapy

Intra-vesical instillations of BCG

Target treatment

What target specific treatments?

Monoclonal antibodies

Trastuzumab (Herceptin™)

Rituximab (Mabthera™ , Rituxan™ )

Alemtuzumab (Mabcampath™, Campath™)

Cetuximab (Erbitux™)

Active small molecules

STI-571 ou Imatinib mesylate (Glivec™, Gleevec™)

Gefitinib (Iressa™)

Erlotinib (Tarceva)

Anti-angiogenic treatment

Bevacizumab (Avastin™)

Thalidomide

Anti-proteasome treatment

Bortezomib (Velcade™)

Other innovating drugs will sooner or later join this incomplete list over the following months or years. Some data may be incomplete. Thank you to my colleagues who may wish to offer suggestions or remarks.

Other chapters of this website

References
Index
 
New treatments of cancer - You are looking at www.oncoprof.net website